These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. Wilhelmsen L; Berglund G; Elmfeldt D; Fitzsimons T; Holzgreve H; Hosie J; Hörnkvist PE; Pennert K; Tuomilehto J; Wedel H J Hypertens; 1987 Oct; 5(5):561-72. PubMed ID: 2892881 [TBL] [Abstract][Full Text] [Related]
6. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. Wikstrand J; Warnold I; Olsson G; Tuomilehto J; Elmfeldt D; Berglund G JAMA; 1988 Apr; 259(13):1976-82. PubMed ID: 3346979 [TBL] [Abstract][Full Text] [Related]
7. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications. Wikstrand J J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139 [TBL] [Abstract][Full Text] [Related]
8. Diuretic agents and beta-blockers in the treatment of hypertension. Dollery C Hypertension; 1989 May; 13(5 Suppl):I62-5. PubMed ID: 2577461 [TBL] [Abstract][Full Text] [Related]
9. Beta-blockers and primary cardioprotection in hypertension. Fogari R; Zoppi A Drugs Exp Clin Res; 1990; 16(3):113-22. PubMed ID: 1974838 [TBL] [Abstract][Full Text] [Related]
10. HAPPHY trial: primary prevention against coronary heart disease with beta-blockers ruled out by HAPPHY? Hansson L J Hypertens; 1987 Oct; 5(5):573-4. PubMed ID: 2892882 [No Abstract] [Full Text] [Related]
12. Coronary artery disease can be prevented by antihypertensive therapy: experiences from the MAPHY Study. Tuomilehto J; Wikstrand J; Warnold I; Olsson G; Elmfeldt D; Berglund G J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S75-6. PubMed ID: 1708032 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diuretics. Johannesson M; Wikstrand J; Jönsson B; Berglund G; Tuomilehto J Pharmacoeconomics; 1993 Jan; 3(1):36-44. PubMed ID: 10146986 [TBL] [Abstract][Full Text] [Related]
14. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study. Olsson G; Tuomilehto J; Berglund G; Elmfeldt D; Warnold I; Barber H; Eliasson K; Jastrup B; Karatzas N; Leer J Am J Hypertens; 1991 Feb; 4(2 Pt 1):151-8. PubMed ID: 2021446 [TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. Samuelsson O; Hedner T; Berglund G; Persson B; Andersson OK; Wilhelmsen L J Hum Hypertens; 1994 Apr; 8(4):257-63. PubMed ID: 7912734 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic trials in arterial hypertension]. Gueyffier F Rev Prat; 1999 Mar; 49(5):512-8. PubMed ID: 10358401 [TBL] [Abstract][Full Text] [Related]
17. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension. Gifford RW Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189 [TBL] [Abstract][Full Text] [Related]
18. Beta-blockers versus thiazide diuretics in the first line drug treatment of hypertension. Beevers DG; Davies P Acta Med Scand Suppl; 1983; 686():75-80. PubMed ID: 6147959 [No Abstract] [Full Text] [Related]
19. Primary prevention in patients with hypertension: comments on the clinical implications of the MAPHY Study. Metoprolol Atherosclerosis Prevention in Hypertensives Study. Wikstrand J Am Heart J; 1988 Jul; 116(1 Pt 2):338-47. PubMed ID: 3293400 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive therapy and the concept of total cardiovascular protection. Mason DT; Chan MC; Lee G Am J Cardiol; 1987 Sep; 60(9):29E-32E. PubMed ID: 2889351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]